Coronary vasomotion dysfunction after everolimus-eluting stent implantation

First generation drug-eluting stent can cause a paradoxical “in-segment” coronary vasoconstriction. This phenomenon was seen with sirolimus, paclitaxel, and, more recently, also with zotarolimus-eluting stent. For the first time, we describe a case of coronary-induced vasoconstriction by everolimus-...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Interv Med Appl Sci
Autors principals: Giudice, Pietro, Attisano, Tiziana, Di Maio, Marco, Bellino, Elisabetta M., Polito, Maria V., Baldi, Cesare, Vigorito, Francesco, Di Muro, Michele R., Tomasello, Salvatore D., Galassi, Alfredo R., Piscione, Federico
Format: Artigo
Idioma:Inglês
Publicat: Akadémiai Kiadó 2014
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4274358/
https://ncbi.nlm.nih.gov/pubmed/25598992
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1556/IMAS.6.2014.4.6
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars